silver has been researched along with zithromax in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, NM; Chavada, VD; Sanyal, M; Shrivastav, PS | 1 |
| Abou-Aisha, K; Akram, FE; El-Azizi, M; El-Tayeb, T | 1 |
2 other study(ies) available for silver and zithromax
| Article | Year |
|---|---|
Surface plasmon resonance based selective and sensitive colorimetric determination of azithromycin using unmodified silver nanoparticles in pharmaceuticals and human plasma.
Topics: Azithromycin; Calibration; Colorimetry; Dynamic Light Scattering; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Pharmaceutical Preparations; Reproducibility of Results; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Surface Plasmon Resonance; Time Factors | 2017 |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Combined Modality Therapy; Drug Combinations; Drug Synergism; Light; Linezolid; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phototherapy; Silver; Vancomycin | 2016 |